ABOUT
Our Commitment
At BIORCHESTRA, we develop innovative medicines for patients and their families, offering hope to cure neglected and incurable diseases and improve the quality of life and health for all.
Vision
Mission
Our programs underpin our unwavering commitment to bring innovative medicines in service to patients, thereby addressing major unmet medical needs
Values
Integrity, Teamwork, Innovation, Scientific Excellence, and Accountability
Corporate Overview
Development Strategy
Target rare and degenerative CNS diseases (AD, ALS, Epilepsy, FTD, HD, PD, Familial PD)
Lead Program
BMD-001: An IV formulated nanomedicine targeting a specific microRNA implicated across CNS diseases, with subsequent clearance of amyloid, reduction in tau protein deposition, decrease in neuroinflammation, and improvement in cognitive function
Pipeline
Broad portfolio of RNA interference chemistries – seven discovery and pre-clinical programs
Brain Targeting Drug Delivery System
Best-in-class technology enabling efficient encapsulation and targeted delivery of RNA therapeutics to brain cells
External Partnering Strategy
Multiple nondisclosed partnerships across a range of targets; additional licensing discussions ongoing
